"Discovery: Gene Variant Offers Strong Protection Against Alzheimer's Disease"
Scientists have discovered a gene variant in the FN1 gene that can reduce the risk of developing Alzheimer's by up to 70% in individuals with the APOEe4 gene variant. This variant helps regulate the amount of fibronectin in the brain, which is crucial for the brain's defense and the clearance of amyloid-beta proteins associated with Alzheimer's. The findings suggest that targeting fibronectin could lead to more effective treatments for the disease, potentially benefiting hundreds of thousands of people in the US alone. Further research is needed to understand how this gene variant provides protection and to develop potential drug therapies.